Basic Information
Awiqli
Regulatory Information
EMEA/H/C/005978
Authorised
May 17, 2024
March 21, 2024
1
March 5, 2025
Company Information
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Treatment of diabetes mellitus in adults
Overview Summary
Awiqli is a medicine used to treat adults with diabetes. It contains the active substance insulin icodec, a long-acting insulin.